PGI4 INCLUSION OF A PENTAVALENT ROTAVIRUS VACCINE IN THE NEW ZEALAND CHILDHOOD IMMUNISATION SCHEDULE
نویسندگان
چکیده
منابع مشابه
Effectiveness of monovalent and pentavalent rotavirus vaccine.
OBJECTIVE Previous US evaluations have not assessed monovalent rotavirus vaccine (RV1, a G1P[8] human rotavirus strain) effectiveness, because of its later introduction (2008). Using case-control methodology, we measured the vaccine effectiveness (VE) of the 2-dose RV1 and 3-dose pentavalent vaccine (RV5) series against rotavirus disease resulting in hospital emergency department or inpatient c...
متن کاملCost effectiveness of a pentavalent rotavirus vaccine in Oman
BACKGROUND Rotavirus gastroenteritis (RGE) is the leading cause of diarrhea in young children in Oman, incurring substantial healthcare and economic burden. We propose to formally assess the potential cost effectiveness of implementing universal vaccination with a pentavalent rotavirus vaccine (RV5) on reducing the health care burden and costs associated with rotavirus gastroenteritis (RGE) in ...
متن کاملPentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia.
OBJECTIVE A publicly funded, universal infant pentavalent rotavirus vaccine (RV5) program was implemented in Queensland, Australia, in mid-2007. We sought to assess vaccine effectiveness (VE) of 3 doses of RV5 at preventing rotavirus and nonrotavirus acute gastroenteritis (AGE) hospitalizations in the first birth cohort and impact on hospitalizations in all age groups. METHODS Hospitalization...
متن کاملBarriers to childhood immunisation among New Zealand mothers
Parental knowledge of, and attitudes towards, immunisation and the diseases that vaccines protect against are important determinants of a decision to vaccinate children. This study addresses parents’ beliefs and perceptions about childhood immunisation and identifies potential and existing barriers. Focus groups and one-onone interviews were held with New Zealand European and Maori mothers of s...
متن کاملComparative analysis of pentavalent rotavirus vaccine strains and G8 rotaviruses identified during vaccine trial in Africa
RotaTeqTM is a pentavalent rotavirus vaccine based on a bovine rotavirus genetic backbone in vitro reassorted with human outer capsid genes. During clinical trials of RotaTeqTM in Sub-Saharan Africa, the vaccine efficacy over a 2-year follow-up was lower against the genotypes contained in the vaccine than against the heterotypic G8P[6] and G8P[1] rotavirus strains of which the former is highly ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2007
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)68987-5